The purpose of the Research Scientist, Japan Value, Evidence and Outcomes (Japan VEO) is to deliver valuable evidence that addresses health outcomes issues, maximizes product value in Lilly portfolio, and contributes to improvement of people s health by demonstrating scientific leadership in evidence strategy development, planning, HEOR/RWE study development and execution.
- The research scientist will provide strategic insight/leadership into the health outcomes (HO) evidence needs (eg, health economics, patient reported outcomes, real world evidence) for Lilly s portfolio
- The scientist will integrate their knowledge of health outcomes disciplines, therapeutic area knowledge of disease states in the Lilly portfolio, understanding of drug development and commercialization, and local market knowledge in the role to deliver valuable evidence, partnering with global VEO/VEO International as well as local functions
- Research project ownership and execution is required
- The scientist may have duties ranging from developing and articulating product value propositions,
patient reported outcomes strategies, real world evidence generation, and differentiation strategies using HO research depending on the individual assignment
Primary Responsibilities :
This job description is intended to provide a general overview of the job requirements at the time it was prepared. The job requirements of any position may change over time and may include additional responsibilities not specifically described in the job description. Consult with your supervision regarding your actual job responsibilities and any related duties that may be required for the position.
Strategy
- Develops and oversees local HEOR/RWE strategy for compounds in the Lilly portfolio in Japan in the relevant therapeutic area(s) that is aligned with local product strategy and global/regional HEOR/RWE strategy.
- Drives sustained integration of HEOR/RWE from early clinical development through commercialization depe